# Arrize Xtech

Arrize Xtech is an Asset Manager.

## Overview

- **Organization type:** Asset Manager
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

Arrize Xtech was founded by Amit Nautiyal, who previously operated in the technology and investment sectors. The firm's wealth origin has not been publicly disclosed, though it is structured to manage capital linked to the Nautiyal family alongside external co-investors. The firm targets early- to growth-stage companies across enterprise software, AI/ML, and digital health. Arrize Xtech typically leads or co-invests in rounds, deploying capital through direct equity positions and structured SPVs. Public record deals include participation in a US$12M Series A round for a healthcare AI platform in 2021, and a US$8M seed round for an enterprise data analytics company in 2020 (per SEC filings). Geographic focus is primarily North America, with selective exposure to European technology hubs. Arrize Xtech operates with a lean team of fewer than 10 professionals, based primarily in the United States. The firm does not maintain publicly listed offices outside its principal location. In recent years, Arrize Xtech has focused on building a concentrated portfolio of 10–15 active positions, with an emphasis on data-driven decision-making and operational support for portfolio companies. The firm's structural differentiator lies in its hybrid model: it operates as a single-family office for the Nautiyal family while also raising external capital through structured vehicles, allowing it to scale beyond typical family-office constraints. This dual structure enables Arrize Xtech to pursue larger transactions while retaining the governance and long-term horizon of a family office.

## Sectors

- AI/ML
- Enterprise Software
- Digital Health

## People

- Amit Nautiyal — Founder & Managing Partner

## Questions

### What investment stages does Arrize Xtech typically target?

Arrize Xtech focuses on early- to growth-stage investments, including Series A and seed rounds. Based on public records, the firm has participated in a US$12M Series A and a US$8M seed round.Sector preferences lean toward enterprise software, AI, and digital health.

## Related profiles

- [Brookfield Investments Corporation](https://altss.com/profile/brookfield-ventures)
- [Rehab Medical](https://altss.com/profile/rehab-medical)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/arrize-xtech

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology